LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| Hs 578T | LDN-193189 | 0.3463 |
| MCF7 | Momelotinib | 0.3468 |
| MCF 10A | HG-5-113-01 | 0.3487 |
| Hs 578T | XMD11-50 | 0.3520 |
| MDA-MB-231 | Y39983 | 0.3522 |
| BT-20 | HG-6-64-01 | 0.3550 |
| MDA-MB-231 | Neratinib | 0.3586 |
| MCF7 | Canertinib | 0.3586 |
| SK-BR-3 | Sigma A6730 | 0.3587 |
| Hs 578T | Fedratinib | 0.3610 |
| SK-BR-3 | Y39983 | 0.3613 |
| MDA-MB-231 | JW-7-24-1 | 0.3625 |
| MCF7 | Dovitinib | 0.3654 |
| Hs 578T | Momelotinib | 0.3665 |
| BT-20 | MK2206 | 0.3675 |
| SK-BR-3 | HG-6-64-01 | 0.3681 |
| MDA-MB-231 | GSK1059615 | 0.3713 |
| Hs 578T | Sirolimus | 0.3724 |
| MDA-MB-231 | BMS345541 | 0.3729 |
| MDA-MB-231 | QL-X-138 | 0.3736 |
| MDA-MB-231 | Afatinib | 0.3747 |
| MCF 10A | WH-4-025 | 0.3754 |
| MCF 10A | PF477736 | 0.3770 |
| Hs 578T | Nintedanib | 0.3775 |
| MCF 10A | Palbociclib | 0.3786 |